{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:56:24Z","timestamp":1793105784023,"version":"4.5.0"},"reference-count":37,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>Hospital at home (HAH) replaces acute inpatient hospital care for selected patients by providing care in their homes. We sought to describe the characteristics, management, and complications of patients with osteoarticular infections (OAIs) treated in an HAH program and its economic impact.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We conducted a retrospective observational study evaluating an HAH program in a pediatric hospital in Spain, describing the characteristics of patients with confirmed OAIs requiring intravenous antibiotic therapy admitted to this program between January 2019 and December 2022. The program operates as a virtual ward with possible daily visits by physicians and nurses and 24\/7 telephone contact.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>A total of 88 patients (median age, 4.1 years; interquartile range [IQR], 1.7\u201310.6) with OIAs were admitted to the HAH program. Osteomyelitis (57%) and septic arthritis (29%) were the most frequent infections. Cefuroxime (42%) and cefazolin (39%) were the most frequently prescribed antibiotics. Caregiver self-administration was performed in 99%, allowing multiple daily doses of antimicrobial therapy, 80% by peripheral line. Thirteen patients (15%) had drug-related adverse events, only 3 requiring drug modification. Two patients (2%) were readmitted during HAH, and 1 was readmitted within 30 days of HAH discharge. The median HAH stay was 7 days (IQR, 4\u20138.75). For osteomyelitis, hospital days lowered from 8.5 days (IQR, 4.5\u201312) to 4 days (IQR, 3\u20137) after HAH implementation (P = .005) with 68% per-patient estimated cost savings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>HAH treatment of OAIs is effective and cost-efficient. Patient support by medical and nursing staff, adequate family training, and regular communication are essential to ensure safe home admission.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2023-007265","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T08:19:59Z","timestamp":1704701999000},"page":"75-83","source":"Crossref","is-referenced-by-count":9,"title":["Hospital at Home Program for the Treatment of Pediatric Osteoarticular Infections"],"prefix":"10.1542","volume":"14","author":[{"given":"Beatriz","family":"Ag\u00fandez Reigosa","sequence":"first","affiliation":[{"name":"aHospital at Home Program, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel M.","family":"Cabrera L\u00f3pez","sequence":"additional","affiliation":[{"name":"aHospital at Home Program, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"S\u00e1nchez Marcos","sequence":"additional","affiliation":[{"name":"bDepartment of Pediatrics, Hospital Universitario de Fuenlabrada, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gal\u00e1n-Olleros","sequence":"additional","affiliation":[{"name":"cDepartment of Orthopaedic Surgery and Traumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"S\u00e1nchez Olivier","sequence":"additional","affiliation":[{"name":"aHospital at Home Program, Department of Pediatrics"},{"name":"dDepartment of Pediatrics, Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Calleja Gero","sequence":"additional","affiliation":[{"name":"dDepartment of Pediatrics, Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Jim\u00e9nez Garc\u00eda","sequence":"additional","affiliation":[{"name":"aHospital at Home Program, Department of Pediatrics"},{"name":"dDepartment of Pediatrics, Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"2024020102585070500_B1","author":"Montalto"},{"issue":"9","key":"2024020102585070500_B2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1157\/13085746","article-title":"Veinticinco a\u00f1os de hospitalizaci\u00f3n a domicilio en Espa\u00f1a","volume":"126","author":"Gonz\u00e1lez-Ramallo","year":"2006","journal-title":"Med Clin (Barc)"},{"issue":"6","key":"2024020102585070500_B3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/jpc.15870","article-title":"Home\u2013hospital care for children with acute illnesses: a 2-year follow-up study","volume":"58","author":"Cabrera L\u00f3pez","year":"2022","journal-title":"J Paediatrics Child Health"},{"issue":"10","key":"2024020102585070500_B4","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/archdischild-2015-309731","article-title":"The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy","volume":"101","author":"Hodgson","year":"2016","journal-title":"Arch Dis Child"},{"issue":"3","key":"2024020102585070500_B5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/fmb.15.141","article-title":"Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry","volume":"11","author":"Mir\u00f3n-Rubio","year":"2016","journal-title":"Future Microbiol"},{"issue":"1","key":"2024020102585070500_B6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.22585\/hospdomic.v1i1.8","article-title":"La hospitalizaci\u00f3n a domicilio en el siglo XXI","volume":"1","author":"Massa Dom\u00ednguez","year":"2017","journal-title":"Hosp Domic"},{"issue":"2","key":"2024020102585070500_B7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jac\/dku401","article-title":"Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement","volume":"70","author":"Patel","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"2024020102585070500_B8","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1097\/INF.0000000000002031","article-title":"The impact of pediatric outpatient parenteral antibiotic therapy implementation at a tertiary children\u2019s hospital in the United Kingdom","volume":"37","author":"Patel","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2024020102585070500_B9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2017.03.016","article-title":"Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service","volume":"51","author":"Durojaiye","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"2024020102585070500_B10","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/0009922810374210","article-title":"Complications associated with outpatient parenteral antibiotic therapy in children","volume":"49","author":"Le","year":"2010","journal-title":"Clin Pediatr (Phila)"},{"issue":"2","key":"2024020102585070500_B11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jpids\/piu037","article-title":"Adverse events in pediatric patients receiving long-term outpatient antimicrobials","volume":"4","author":"Olson","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"12","key":"2024020102585070500_B12","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/INF.0b013e31817d32f2","article-title":"Experience using peripherally inserted central venous catheters for outpatient parenteral antibiotic therapy in children at a community hospital","volume":"27","author":"Van Winkle","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2024020102585070500_B13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/ice.2015.317","article-title":"Peripherally inserted central venous catheter complications in children receiving outpatient parenteral antibiotic therapy (OPAT)","volume":"37","author":"Kovacich","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"2024020102585070500_B14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/INF.0b013e31827ee1c2","article-title":"Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children\u2019s hospital","volume":"32","author":"Madigan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2024020102585070500_B15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/INF.0000000000001635","article-title":"Bone and joint infections","volume":"36","author":"Saavedra-Lozano","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"2024020102585070500_B16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/INF.0000000000001309","article-title":"Epidemiology and management of acute, uncomplicated septic arthritis and osteomyelitis: Spanish multicenter study","volume":"35","author":"Calvo","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2024020102585070500_B17","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/S1473-3099(16)30024-X","article-title":"Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines","volume":"16","author":"McMullan","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"2024020102585070500_B18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/INF.0b013e3181f55a89","article-title":"Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases","volume":"29","author":"Peltola","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2024020102585070500_B19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/archdischild-2019-317629","article-title":"Being \u2018at-home\u2019 on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents\u2019 experiences of paediatric OPAT","volume":"105","author":"Carter","year":"2020","journal-title":"Arch Dis Child"},{"issue":"5","key":"2024020102585070500_B20","doi-asserted-by":"crossref","first-page":"e12910","DOI":"10.1111\/ijn.12910","article-title":"The effect of parental participation in the care of hospitalized children on parent satisfaction and parent and child anxiety: randomized controlled trial","volume":"27","author":"\u00c7amur","year":"2021","journal-title":"Int J Nurs Pract"},{"issue":"6","key":"2024020102585070500_B21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.paed.2013.03.003","article-title":"What is Hospital at Home? Could Hospital at Home be a feasible option for acutely unwell paediatric patients?","volume":"23","author":"Thomas","year":"2013","journal-title":"Paediatr Child Health"},{"issue":"9","key":"2024020102585070500_B22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/INF.0000000000001605","article-title":"A comparison of hospital versus outpatient parenteral antibiotic therapy at home for pyelonephritis and meningitis","volume":"36","author":"Hensey","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2024020102585070500_B23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jamapediatrics.2016.4812","article-title":"Families as partners in hospital error and adverse event surveillance","volume":"171","author":"Khan","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"2","key":"2024020102585070500_B24","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S1473-3099(17)30345-6","article-title":"Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review","volume":"18","author":"Bryant","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2024020102585070500_B25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.12968\/hmed.2018.79.1.12","article-title":"Outpatient parenteral antimicrobial therapy","volume":"79","author":"Bellamy","year":"2018","journal-title":"Br J Hosp Med (Lond)"},{"key":"2024020102585070500_B26","doi-asserted-by":"crossref","first-page":"103652","DOI":"10.1016\/j.ijnurstu.2020.103652","article-title":"The risk of overestimating cost savings from hospital-at-home schemes: a literature review","volume":"109","author":"Goossens","year":"2020","journal-title":"Int J Nurs Stud"},{"issue":"2","key":"2024020102585070500_B27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/INF.0000000000001716","article-title":"Safety of outpatient parenteral antimicrobial therapy in children","volume":"37","author":"Fernandes","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2024020102585070500_B28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00006454-200105000-00015","article-title":"Complications of outpatient parenteral antibiotic therapy in childhood","volume":"20","author":"Gomez","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2024020102585070500_B29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10096-016-2606-z","article-title":"Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity","volume":"35","author":"Gardiol","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"2024020102585070500_B30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/01241398-200207000-00017","article-title":"Outpatient parenteral antimicrobial therapy in osteoarticular infections in children","volume":"22","author":"Maraqa","year":"2002","journal-title":"J Pediatr Orthop"},{"issue":"11","key":"2024020102585070500_B31","doi-asserted-by":"crossref","first-page":"e021603","DOI":"10.1136\/bmjopen-2018-021603","article-title":"Delivery, setting and outcomes of paediatric outpatient parenteral antimicrobial therapy (OPAT): a scoping review","volume":"8","author":"Carter","year":"2018","journal-title":"BMJ Open"},{"issue":"4","key":"2024020102585070500_B32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dku517","article-title":"Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists","volume":"70","author":"Gilchrist","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2024020102585070500_B33","doi-asserted-by":"crossref","first-page":"273.e1","DOI":"10.1016\/j.anpedi.2014.10.005","article-title":"Documento de consenso SEIP-SERPE-SEOP sobre el tratamiento de la osteomielitis aguda y artritis s\u00e9ptica no complicadas","volume":"82","author":"Saavedra-Lozano","year":"2015","journal-title":"An Pediatr (Barc)"},{"issue":"9","key":"2024020102585070500_B34","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1097\/INF.0000000000003619","article-title":"Oral versus intravenous antibiotics for pediatric osteoarticular infection: when and to whom?","volume":"41","author":"Alcobendas Rueda","year":"2022","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2024020102585070500_B35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1542\/hpeds.2018-0279","article-title":"To discharge or not to discharge on outpatient parenteral antimicrobial therapy: that is the question","volume":"9","author":"Markham","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"4","key":"2024020102585070500_B36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1542\/hpeds.2018-0193","article-title":"Economic burden of home antimicrobial therapy: OPAT versus oral therapy","volume":"9","author":"Krah","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"1","key":"2024020102585070500_B37","first-page":"65","article-title":"Outpatient parenteral antimicrobial therapy in pediatric medicaid enrollees","volume":"6","author":"Goldman","year":"2017","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/14\/2\/75\/1593695\/hpeds.2023-007265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/14\/2\/75\/1593695\/hpeds.2023-007265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T02:59:21Z","timestamp":1706756361000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/14\/2\/75\/196389\/Hospital-at-Home-Program-for-the-Treatment-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2023-007265","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]}}}